- Home
- SKBL vs TKNO Comparison
SKBL vs TKNO Comparison
Compare SKBL & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKBL
- TKNO
- Stock Information
- Founded
- SKBL 2012
- TKNO 1996
- Country
- SKBL Hong Kong
- TKNO United States
- Employees
- SKBL N/A
- TKNO N/A
- Industry
- SKBL
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- SKBL
- TKNO Health Care
- Exchange
- SKBL NYSE
- TKNO Nasdaq
- Market Cap
- SKBL 302.6M
- TKNO 356.4M
- IPO Year
- SKBL 2025
- TKNO 2021
- Fundamental
- Price
- SKBL $1.55
- TKNO $4.81
- Analyst Decision
- SKBL
- TKNO Buy
- Analyst Count
- SKBL 0
- TKNO 1
- Target Price
- SKBL N/A
- TKNO $5.00
- AVG Volume (30 Days)
- SKBL 2.3M
- TKNO 316.4K
- Earning Date
- SKBL 01-01-0001
- TKNO 08-12-2025
- Dividend Yield
- SKBL N/A
- TKNO N/A
- EPS Growth
- SKBL N/A
- TKNO N/A
- EPS
- SKBL 0.03
- TKNO N/A
- Revenue
- SKBL $49,638,709.00
- TKNO $38,250,000.00
- Revenue This Year
- SKBL N/A
- TKNO $8.73
- Revenue Next Year
- SKBL N/A
- TKNO $16.53
- P/E Ratio
- SKBL $45.44
- TKNO N/A
- Revenue Growth
- SKBL 9.58
- TKNO 3.79
- 52 Week Low
- SKBL $0.99
- TKNO $1.21
- 52 Week High
- SKBL $14.25
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- SKBL N/A
- TKNO 35.41
- Support Level
- SKBL N/A
- TKNO $4.90
- Resistance Level
- SKBL N/A
- TKNO $5.38
- Average True Range (ATR)
- SKBL 0.00
- TKNO 0.33
- MACD
- SKBL 0.00
- TKNO 0.01
- Stochastic Oscillator
- SKBL 0.00
- TKNO 13.41
About SKBL SKYLINE BUILDERS GROUP HOLDING LIMI
Skyline Builders Group Holding Ltd is an holding company operates through its subsidiary. It is a Public Works Contractor company undertaking roads and drainage in Hong Kong. Its construction activities mainly include public civil engineering works, such as road and drainage works, in Hong Kong.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.